Sionna Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary

Sionna Therapeutics

06/08/2026 14:21

Sionna Therapeutics, Inc. SION.OQ reported a quarterly adjusted loss of 66 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -41 cents.  The mean expectation of eleven analysts for the quarter was for a loss of 65 cents per share. Wall Street expected results to range from -74 cents to -61 cents per share.
Reported revenue was zero​; analysts expected zero. 
Sionna Therapeutics, Inc.'s reported EPS for the quarter was a loss of 66 cents​.
The company reported a quarterly loss of $29.89 million.
Sionna Therapeutics, Inc. shares had risen by 7.6% this quarter and gained 15.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 17.7% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Sionna Therapeutics, Inc. is $54.00, about 12.3% above its last closing price of $47.34
This summary was machine generated from LSEG data August 6 at 01:21 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.65
-0.66
Missed
Mar. 31 2026 
-0.51
-0.60
Missed
Dec. 31 2025 
-0.54
-0.46
Beat
Sep. 30 2025 
-0.48
-0.46
Beat